Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility

By Pharmaceutical Processing | November 11, 2010

Dendreon Corporation has completed the submission of the
post-approval supplement to the PROVENGE (sipuleucel-T) Biologics License
Application for the Morris Plains, New
Jersey manufacturing facility. Dendreon is requesting
licensure for an additional 36 workstations to manufacture PROVENGE. The
standard U.S. Food and Drug Administration (FDA) review for a post-approval
supplement to a Biologics License Application is typically four months.

“The submission requesting licensure for additional
capacity of the New Jersey manufacturing facility is an important milestone as
we work to make PROVENGE more widely available to the many patients who may benefit
from it,” said Mitchell H. Gold, M.D., president and chief executive
officer.

Dendreon’s manufacturing facility in Morris
Plains, New Jersey is currently operating at 25
percent capacity, with 12 workstations available to manufacture PROVENGE. With
the FDA approval of the post-approval supplement to the Biologics License
Application, the facility will have a total of 48 workstations. PROVENGE is the
first in a new therapeutic class known as autologous cellular immunotherapies.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE